CXE vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CXE presents a stable Piotroski F-Score of 5/9, but this is overshadowed by severe valuation disconnects and unsustainable payout metrics. The stock trades at $3.74, vastly exceeding its Graham Number of $0.97 and an Intrinsic Value of $0.07. With a P/E ratio of 374.00 and a dividend payout ratio of 2070%, the current price is not supported by earnings or cash flow. Negative earnings growth (-16.5%) and a critical liquidity position (Current Ratio 0.27) further degrade the investment profile.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
CXE vs JPM: Head-to-Head Comparison
This page compares MFS High Income Municipal Trust (CXE) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.